Inventor · disambiguated record
Manuel Baca
Also filed as: BACA MANUEL
37 granted patents·27 pending applications·1,519 citations·filing 1997–2025
98Inventor score
Top patents by PatentIndex Score
64 records- 0199US7365166B2Anti-VEGF antibodiesGENENTECH INC·Filed 2006·Granted Apr 29, 2008·90 cites·7 claims
- 0299US7169901B2Anti-VEGF antibodiesGENENTECH INC·Filed 2002·Granted Jan 30, 2007·160 cites·12 claims
- 0399US7060269B1Anti-VEGF antibodiesGENENTECH INC·Filed 2000·Granted Jun 13, 2006·342 cites·2 claims
- 0499US6884879B1Anti-VEGF antibodiesGENENTECH INC·Filed 1997·Granted Apr 26, 2005·623 cites·14 claims
- 0598US7375193B2Anti-VEGF antibodiesGENENTECH INC·Filed 2006·Granted May 20, 2008·62 cites·22 claims
- 0697US7297334B2Anti-vegf antibodiesGENENTECH INC·Filed 2004·Granted Nov 20, 2007·112 cites·9 claims
- 0795US11124582B2FLT3L-FC fusion proteinsGILEAD SCIENCES INC·Filed 2020·Granted Sep 21, 2021·16 cites·1 claims
- 0893US7993637B2IL-11 muteinsCSL LTD·Filed 2008·Granted Aug 9, 2011·20 cites·11 claims
- 0992US8182814B2Methods of treating inflammatory airway conditions by inhibition of IL-11 activityBACA MANUEL·Filed 2008·Granted May 22, 2012·22 cites·16 claims
- 1091US8540977B2IL-11 muteinsBACA MANUEL·Filed 2011·Granted Sep 24, 2013·18 cites·12 claims
- 1191US7754213B2High affinity antibody antagonists of interleukin-13 receptor alpha 1MERCK & CO INC·Filed 2007·Granted Jul 13, 2010·13 cites·7 claims
- 1286US2025051462A1Antibodies against g-csfr and uses thereofCSL LTD·Filed 2024·Application pending·0 cites
- 1383US10000553B2CD40L-specific TN3-derived scaffolds and methods of use thereofMEDIMMUNE LLC·Filed 2012·Granted Jun 19, 2018·6 cites·19 claims
- 1482US9193793B2Antibodies against G-CSFR and uses thereofNASH ANDREW DONALD·Filed 2012·Granted Nov 24, 2015·6 cites·21 claims
- 1579US9371388B2High affinity antibody antagonists of interleukin-13 receptor alpha 1CSL LTD·Filed 2013·Granted Jun 21, 2016·2 cites·4 claims
- 1678US8633297B2Protein scaffoldsWU HERREN·Filed 2008·Granted Jan 21, 2014·4 cites·17 claims
- 1778US7517959B2SOCS3 proteinsINST MEDICAL W & E HALL·Filed 2006·Granted Apr 14, 2009·3 cites·11 claims
- 1878US2023242619A1Compositions comprising a tn3 scaffold and methods of using the sameVIELA BIO INC·Filed 2022·Application pending·0 cites
- 1976US9777062B2High affinity antibody antagonists of interleukin-13 receptor alpha 1CSL LTD·Filed 2016·Granted Oct 3, 2017·1 cites·10 claims
- 2076US8568722B2High affinity antibody antagonists of interleukin-13 receptor alpha 1NASH ANDREW DONALD·Filed 2010·Granted Oct 29, 2013·2 cites·2 claims
- 2174US11555062B2Methods of administering a composition comprising a Tn3 scaffold and a CD40L-specific monomerVIELA BIO INC·Filed 2021·Granted Jan 17, 2023·0 cites·39 claims
- 2272US2025257120A1Compositions comprising a tn3 scaffold and methods of using the sameVIELA BIO INC·Filed 2025·Application pending·0 cites
- 2371US12071484B2Nucleic acids encoding antibodies against human granulocyte-colony stimulating factor receptor (G-CSFR) and method of expressing encoded proteinCSL LTD·Filed 2020·Granted Aug 27, 2024·0 cites·14 claims
- 2471US8613925B2Anti-IL-13Rα1 antibodies and their uses thereofNASH ANDREW DONALD·Filed 2007·Granted Dec 24, 2013·1 cites·9 claims
- 2570US2025059261A1Multi-specific antigen binding molecules targeting hiv and methods of useGILEAD SCIENCES INC·Filed 2024·Application pending·0 cites
- 2669US9176129B2Protein scaffoldsMEDIMMUNE LLC·Filed 2013·Granted Nov 3, 2015·1 cites·20 claims
- 2768US8221755B2Monoclonal antibody against interleukin-13 receptor alpha 1 (IL-13Ralpha1)DUNLOP FELICITY MEREDITH·Filed 2010·Granted Jul 17, 2012·2 cites·4 claims
- 2868US7785590B2Monoclonal antibody against interleukin-13 receptor alpha 1 (IL-13Ra1)ZENYTH OPERATIONS PTY LTD·Filed 2004·Granted Aug 31, 2010·3 cites·12 claims
- 2968US2008226629A1Anti-vegf antibodiesGENENTECH INC·Filed 2008·Application pending·0 cites
- 3068US2024269235A1INTERLEUKIN-2-Fc FUSION PROTEINS AND METHODS OF USEGILEAD SCIENCES INC·Filed 2023·Application pending·0 cites
- 3166US12195524B2Multi-specific antigen binding molecules targeting HIV and methods of useGILEAD SCIENCES INC·Filed 2021·Granted Jan 14, 2025·0 cites·21 claims
- 3266US11896648B2Interleukin-2 variant proteins fused to human IgG4 Fc and uses thereofGILEAD SCIENCES INC·Filed 2021·Granted Feb 13, 2024·0 cites·14 claims
- 3366US9212231B2TRAIL R2-specific multimeric scaffoldsBACA MANUEL·Filed 2011·Granted Dec 15, 2015·1 cites·24 claims
- 3466US2022049021A1FLT3L-Fc FUSION PROTEINS AND METHODS OF USEGILEAD SCIENCES INC·Filed 2021·Application pending·0 cites
- 3566US2008187534A1Anti-vegf antibodiesGENENTECH INC·Filed 2008·Application pending·0 cites
- 3665US7256007B2Methods of regulating cytokine signallingINST MEDICAL W & E HALL·Filed 2001·Granted Aug 14, 2007·2 cites·17 claims
- 3764US10106617B2High affinity antibody antagonists of interleukin-13 receptor alpha 1CSL LTD·Filed 2017·Granted Oct 23, 2018·0 cites·12 claims
- 3863US7919471B2Method of modulating cell survival and reagents useful for sameUNIV QUEENSLAND·Filed 2004·Granted Apr 5, 2011·3 cites·3 claims
- 3963US2007196374A1Anti-vegf antibodiesBACA MANUEL·Filed 2006·Application pending·0 cites
- 4063US2019055313A1Antibodies against g-csfr and uses thereofCSL LTD·Filed 2018·Application pending·0 cites
- 4162US10883087B2Uricase sequences and methods of treatmentMEDIMMUNE LLC·Filed 2018·Granted Jan 5, 2021·0 cites·12 claims
- 4262US2021009718A1FLT3L-Fc FUSION PROTEINS AND METHODS OF USEGILEAD SCIENCES INC·Filed 2020·Application pending·0 cites
- 4362US2013058927A1Anti-vegf antibodiesGENENTECH INC·Filed 2012·Application pending·0 cites
- 4460US2021254024A1Uricase sequences and methods of treatmentMEDIMMUNE LLC·Filed 2020·Application pending·0 cites
- 4559US7683213B2Oxidation of propane to give acrylic acid using catalysts in a mixture of crystalline phasesARKEMA·Filed 2004·Granted Mar 23, 2010·3 cites·9 claims
- 4659US2017226214A1Antibodies against g-csfr and uses thereofCSL LTD·Filed 2017·Application pending·0 cites
- 4759US2006242718A1SOCS-box containing peptidesWILLSON TRACY A·Filed 2006·Application pending·0 cites
- 4858US11098289B2Uricase sequences and methods of treatmentMEDIMMUNE LLC·Filed 2016·Granted Aug 24, 2021·0 cites·8 claims
- 4958US2016257738A1Anti-vegf antibodiesGENENTECH INC·Filed 2015·Application pending·0 cites
- 5058US2011052575A1Anti-vegf antibodiesGENENTECH INC·Filed 2010·Application pending·0 cites
Showing the top 50 of 64 patent records by PatentIndex Score.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →